Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Insmed Announces Results Of IPLEX(TM) Phase II Trial In Myotonic Muscular Dystrophy
Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, announced results from its exploratory U.S. Phase II clinical trial evaluating IPLEX(TM) (mecasermin rinfabate) in patients with myotonic muscular dystrophy ("MMD"). The randomized, double-blind, placebo-controlled Phase II trial conducted in 13 centers across the U.S. enrolled 69 patients with MMD, for a six-month period. As this was an exploratory trial, a primary endpoint was not pre-defined. The trial explored measures of endurance, using the six-minute walk test, muscle function and strength, cognitive function, gastrointestinal function, pain, quality of life, insulin sensitivity, lipid metabolism, and safety and tolerability of IPLEX(TM).
generic viagra online
Owners Of A Brechin Rendering Plant Fined ÷£12,000 After Workers Overcome By Toxic Fumes
The owners of a Brechin rendering plant have been convicted of failing to ensure proper health and safety standards were in place, after two workers were overcome by fumes produced by rotting animal waste.
News of the day
UC Davis Researchers Develop New Test For Fragile X Syndrome
Researchers at UC Davis have developed a new test that will measure the protein deficit responsible for fragile X syndrome - the single-most common cause of intellectual impairment and the most-commonly inherited cause of autism. The test, described in a study appearing online in the July 2009 issue of The Journal of Molecular Diagnostics, is the first to measure an individual"s level of the fragile X mental retardation 1 (FMR1) protein.
Sexual Health

ReachMD Launches CME iPhone APP

ReachMD, which provides medical news and information to healthcare practitioners, is raising its profile with the Continuing Medical Education, or CME, application for the Apple iPhone and iPod touch. This is the first CME application that lets users listen to all ReachMD Continuing Medical Education content, get regular updates on new Continuing Medical Education content and take Continuing Medical Education tests for credit, all from their iPhone or iPod touch. "This platform was created by medical professionals for medical professionals, including physicians, pharmacists, nurse practitioners and those in medical profession with a clinical bent, to provide continuing medical education for credit," said Gary Epstein, CEO of ReachMD Established to help increasingly time-constrained medical providers stay abreast of new research, treatment protocols and continuing education requirements, ReachMD delivers informative radio programming via XM Satellite Radio Channel 160 and online streaming developed by doctors for doctors. The ReachMD CME iPhone application is a fully accredited Continuing Medical Education tool that gives healthcare practitioners a convenient way to earn free CME credits through their iPhone or iPod touch. Doctors can download the ReachMD CME iPhone app to listen to the program and take the CME certification test from an iPhone, an iPod touch or the ReachMD Web site. The ReachMD Continuing Medical Education iPhone app lets physicians go back to exams they were previously working on after taking a phone call and search for Continuing Medical Education programs by keywords. The application automatically receives updates with new Continuing Medical Education programs and alerts for new programs and information. "We"ll be rolling out a deeper app in June that will include a radio channel on a 24/7 basis, and we"re looking at advertising on some of the landing pages," continued Epstein. ReachMD will launch applications for RIM"s BlackBerry and Google"s Android this summer. ReachMD


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009